IP Library Granted Patent US 8,223,021
Granted Patent B2
US 8,223,021 · App. 12/625,522 · Granted Jul 17, 2012

RF tag on test strips, test strip vials and boxes

Assignee: Abbott Diabetes Care Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,223,021
App. No.
12/625,522
Granted
Jul 17, 2012
Kind
B2
Abstract

A glucose monitoring system, includes a glucose sensor strip or package of strips. The strip includes a substrate and a glucose monitoring circuit that has electrodes and a bodily fluid application portion of selected chemical composition. An antenna is integrated with the glucose sensor strip. A RFID sensor chip is coupled with the glucose sensor strip and the antenna. The chip has a memory containing digitally-encoded data representing calibration and/or expiration date information for the strip.

Claims (34)

1. A glucose monitoring device, comprising:

a housing;

an output unit coupled to the housing for outputting information related to a monitored analyte level;

an antenna coupled to the housing; and

a radio frequency identification (RFID) reader component coupled to the housing and the antenna, the RFID reader component configured to transmit a radio frequency (RF) signal and to detect a backscattering radio wave including digitally encoded data representing the analyte level determined by an analyte sensor.

2. The device of claim 1 including a data communication unit for communicating data related to the monitored analyte level.

3. The device of claim 2 , where in the data communication unit includes a universal serial bus (USB) connection.

4. The device of claim 3 , wherein the USB connection includes a USB connector coupled to the housing.

5. The device of claim 1 , wherein the antenna comprises one of a loop antenna or a dipole antenna.

6. The device of claim 5 , wherein the loop antenna comprises a conducting loop.

7. The device of claim 1 , wherein the housing includes a strip port configured to receive an in vitro glucose test strip.

8. The device of claim 1 , further including a memory coupled to the RFID reader component, the memory configured to store data representing one or more of a lot information associated with the analyte sensor, a calibration code associated with the analyte sensor, or an analyte sensor expiration information.

9. The device of claim 1 , wherein the RFID reader component detects the backscattering radio wave based on the transmitted RF signal.

10. The device of claim 9 , wherein the transmitted RF signal includes an RF power signal.

11. The device of claim 1 , wherein RFID reader component is configured to operate in an ultra high frequency (UHF) frequency band.

12. The device of claim 1 , wherein the output unit includes a display for displaying an indication related to the determined analyte level.

13. The device of claim 12 , wherein the displayed indication includes a numerical value of a glucose measurement.

14. The device of claim 1 , wherein the digitally encoded data representing the determined analyte level includes a current analyte level data and one or more prior analyte level data determined by the analyte sensor.

15. The device of claim 1 , wherein the detected backscattering radio wave includes digitally encoded data representing expiration date information of one or more in vitro test strips in a container.

16. The device of claim 15 , wherein the container includes one of a package container or a vial container having an RFID tag.

17. The device of claim 16 , wherein the digitally encoded data is stored in the RFID tag.

18. The device of claim 16 , wherein the RFID tag is mounted within the container.

19. The device of claim 16 , wherein the RFID tag includes one of an active tag or a passive tag.

20. The device of claim 15 , wherein the digitally encoded data further includes data representing one or more of a lot number of the test strip, a manufacture date of the test strip, a type of test strip, a calibration code associated with the test strip, a calibration data associated with the test strip, or one or more combinations thereof.

21. A method, comprising:

providing a housing including an output unit;

coupling an antenna to the housing;

coupling a radio frequency identification (RFID) reader component to the housing and the antenna;

transmitting a radio frequency (RF) signal from the RFID reader component and detecting with the RFID reader component a backscattering radio wave including digitally encoded data representing the analyte level determined by an analyte sensor; and

outputting information related to a monitored analyte level to the output unit.

22. The method of claim 21 further including communicating data related to the monitored analyte level.

23. The method of claim 21 , further including coupling a memory to the RFID reader component for storing data representing one or more of a lot information associated with the analyte sensor, a calibration code associated with the analyte sensor, or an analyte sensor expiration information.

24. The method of claim 21 , wherein the backscattering radio wave is detected in response to the transmitted RF signal.

25. The method of claim 24 , wherein the transmitted RF signal includes an RF power signal.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2013
From: GOODNOW, TIMOTHY T.; HE, LAWRENCE
To: THERASENSE, INC.
Reel/Frame 029947/0053 →
CHANGE OF NAME Recorded Mar 7, 2013
From: THERASENSE, INC.
To: ABBOTT DIABETES CARE INC.
Reel/Frame 029947/0373 →
Continuity (5)
Continuation 12476921 · Jun 2, 2009
Continuation 11350398 · Feb 7, 2006
Provisional Application 60701654 · Jul 21, 2005
Provisional Application 60650912 · Feb 8, 2005
Related Publication 20100089750A1 · Apr 15, 2010